Target intelligence / Profile preview

Hemicellulase

Molecular classification
Enzyme, Glycoside hydrolase (Source: Enzyme Nomenclature, EC 3.2.1.8), Hydrolase
01

Overview

Hemicellulase is a collective term for a group of enzymes, primarily of microbial origin, that catalyze the degradation of hemicellulose, a complex carbohydrate found in plant cell walls (Source: PubChem, CID 131751341). Unlike cellulose, hemicellulose is a heteropolymer consisting of various sugars such as xylose, mannose, and galactose, which require specific hydrolases for effective breakdown (Source: Enzyme Nomenclature, EC 3.2.1.8). In therapeutic applications, hemicellulase is utilized as a digestive aid to assist the human gastrointestinal tract in processing complex plant fibers that are otherwise indigestible by endogenous human enzymes. By breaking down these polysaccharides, the enzyme helps prevent the fermentation of undigested matter by colonic bacteria, thereby reducing symptoms of bloating, flatulence, and abdominal discomfort (Source: NIH, PubMed Central PMC6852799). It is frequently included in multi-enzyme formulations alongside pancreatin, amylase, and lipase to manage functional dyspepsia and malabsorption syndromes. While generally considered safe, its use is primarily focused on improving digestive efficiency and nutrient bioavailability in individuals with enzyme deficiencies or those consuming high-fiber diets.

Other names
XylanaseEndo-1,4-beta-xylanaseHemicellulose-degrading enzymeGlucanaseGalactanase
02

Mechanism of action

Catalyzes the hydrolysis of internal 1,4-beta-D-xylosidic linkages in hemicellulose polymers, such as xylan, glucomannan, and galactomannan, converting them into smaller oligosaccharides and monosaccharides (Source: ScienceDirect, Hemicellulases).

03

Biological functions

Carbohydrate metabolism (Source: PubChem, CID 131751341)Digestion of plant polysaccharidesHydrolysis of glycosidic bonds in hemicellulose (Source: Enzyme Nomenclature, EC 3.2.1.8)
04

Disease associations

Dyspepsia (Source: NIH, PubMed Central PMC6852799)FlatulenceMalabsorption syndromeAbdominal bloatingIrritable bowel syndrome (IBS)
05

Safety considerations

Hypersensitivity reactions to fungal-derived proteins (Source: NIH, PubMed Central PMC6852799)Abdominal crampingDiarrhea at high dosesPotential cross-reactivity with Aspergillus allergens
06

Interacting drugs

Pancrelipase

4 more in the full profile.

07

Biomarkers

Reduction in breath hydrogen levels (Source: NIH, PubMed Central PMC6852799)Improvement in Gastrointestinal Symptom Rating Scale (GSRS) scoresStool fiber content reduction

Beyond the preview

Go deeper on Hemicellulase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemicellulase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call